Clinical Trial Update: GLP-1s to Enhance Lasting Optimal Weight [Phase 4]

View source ↗

Summary

This update notes an active Phase 4 trial evaluating GLP-1 receptor agonists to enhance long-term weight loss in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Obesity | Phase 4 | Status: ACTIVE_NOT_RECRUITING